Recent Quarter Total Invested
$4.91 M
Recent Quarter Institutional Ownership Percentage
22.95%
Total Invested of Last Quarter
$9.58 M
Ownership Percentage of Last Quarter
24.32%
Viracta Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 08/14/2024 | 3.61 M | $1.97 M | 0.00% | 9.19% |
| CITADEL ADVISORS LLC | 08/14/2024 | 1.52 M | $826,554 | -2.87% | 3.87% |
| VANGUARD GROUP INC | 08/13/2024 | 1.16 M | $631,388 | 0.00% | 2.95% |
| SAMSARA BIOCAPITAL, LLC | 08/14/2024 | 689,709 | $374,995 | 0.00% | 1.75% |
| LAURION CAPITAL MANAGEMENT LP | 08/14/2024 | 407,299 | $221,448 | -3.12% | 1.04% |
| AISLING CAPITAL MANAGEMENT LP | 08/08/2024 | 288,571 | $156,896 | 0.00% | 0.73% |
| BLACKROCK INC. | 08/13/2024 | 273,297 | $148,592 | -10.09% | 0.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 270,773 | $147,258 | 7.15% | 0.69% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 217,699 | $118,363 | 7.51% | 0.55% |
| MORGAN STANLEY | 08/14/2024 | 134,544 | $73,152 | 14.00% | 0.34% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 74,000 | $40,234 | 0.00% | 0.19% |
| STATE STREET CORP | 08/14/2024 | 65,867 | $35,812 | 0.00% | 0.17% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 61,601 | $33,492 | -2.85% | 0.16% |
| NORTHERN TRUST CORP | 08/14/2024 | 38,104 | $20,717 | -0.23% | 0.10% |
| VIRTU FINANCIAL LLC | 08/09/2024 | 30,789 | $17,000 | 100.00% | 0.08% |
| MAI CAPITAL MANAGEMENT | 08/12/2024 | 27,417 | $14,907 | -92.47% | 0.07% |
| XTX TOPCO LTD | 08/12/2024 | 19,201 | $10,440 | 13.03% | 0.05% |
| INSPIRION WEALTH ADVISORS, LLC | 07/12/2024 | 15,000 | $8,156 | 0.00% | 0.04% |
| BEACON POINTE ADVISORS, LLC | 08/12/2024 | 15,000 | $8,156 | -14.29% | 0.04% |
| HOYLECOHEN, LLC | 07/19/2024 | 14,000 | $7,612 | 0.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 12,652 | $6,883 | 42.33% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 12,496 | $6,785 | 1.83% | 0.03% |
| TRUST CO OF TOLEDO NA /OH/ | 07/08/2024 | 12,317 | $6,697 | 0.00% | 0.03% |
| WEALTHTRUST AXIOM LLC | 08/13/2024 | 11,396 | $6,196 | 0.00% | 0.03% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 10,908 | $5,000 | 0.00% | 0.03% |
| CITADEL ADVISORS LLC | 08/14/2024 | 10,900 | $5,926 | 84.75% | 0.03% |
| SIMPLEX TRADING, LLC | 07/25/2024 | 7,337 | $3,000 | 50.23% | 0.02% |
| PLANNING CAPITAL MANAGEMENT CORP | 08/12/2024 | 7,272 | $3,954 | 0.00% | 0.02% |
| RP MANAGEMENT, LLC | 08/13/2024 | 3,700 | $1,998 | 0.00% | 0.01% |
| IAG WEALTH PARTNERS, LLC | 07/16/2024 | 3,000 | $1,631 | 0.00% | 0.01% |
| BARCLAYS PLC | 08/14/2024 | 2,668 | $1,000 | 0.00% | 0.01% |
| UBS GROUP AG | 08/14/2024 | 1,690 | $920 | 1,678.95% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 721 | $392 | 0.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 400 | $217 | 100.00% | 0.00% |
| INDIANA TRUST & INVESTMENT MANAGEMENT CO | 07/10/2024 | 200 | $109 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 171 | $93 | -55.58% | 0.00% |
| NEWEDGE ADVISORS, LLC | 08/16/2024 | 14 | $8 | 0.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 08/08/2024 | 8 | $4 | 0.00% | 0.00% |
| ADDISON ADVISORS LLC | 08/05/2024 | 4 | $3 | 0.00% | 0.00% |
| PRIVATE OCEAN, LLC | 07/30/2024 | 3 | $2 | 100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 2 | $1 | 0.00% | 0.00% |
| NBC SECURITIES, INC. | 07/10/2024 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| UNITED BANK | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Viracta Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of VIRX shares?
During the previous two years, 46 institutional investors and hedge funds held shares of Viracta Therapeutics, Inc.. The most heavily invested institutionals were:
BVF INC/IL: 3.61 M
CITADEL ADVISORS LLC: 1.52 M
VANGUARD GROUP INC: 1.16 M
Samsara BioCapital, LLC: 689,709
Laurion Capital Management LP: 407,299
Aisling Capital Management LP: 288,571
-
What percentage of Viracta Therapeutics, Inc. stock is owned by institutional investors?
22.95% of Viracta Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at VIRX ?
Institutional investors have bought a total of 9.10 M shares in the last 24 months. This purchase volume represents approximately $2.00 M in transactions.